Massimo Napolitano, MD
Vascular Surgery · Wayne, NJNPI 1316007743
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $128,125 of the $147,408 with a category attached, or 86.9%. Cvrx, Inc. accounts for 70.1% of it on its own, with 13 other manufacturers making up the rest. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $1142.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$103K
- Globus Medical$43K
- Medtronic$471
- Stryker$325
- Alphatec Spine, Inc$142
- Checkpoint Surgical, Inc$96
- plus $295 from 8 others
Across 2 payments — averaging $3258.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Integra Lifesciences Corporation$7K
What the payments were for
- Consulting fees$128,12587%
- Speaking & faculty fees$4,0003%
- Travel & lodging$10,5067%
- Food & beverage$4,7773%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 66 | $103,376 |
| Globus Medical(2 entities) | 41 | $42,703 |
| Medtronic(2 entities) | 9 | $471 |
| Stryker | 2 | $325 |
| Alphatec Spine, Inc | 1 | $142 |
| Checkpoint Surgical, Inc | 1 | $96 |
| W. L. Gore & Associates, Inc. | 1 | $87 |
| Cook Medical LLC | 1 | $48 |
| Artivion, Inc. | 2 | $37 |
| Boston Scientific | 1 | $28 |
| Johnson & Johnson | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $25 |
| Inari Medical, Inc. | 1 | $24 |
| DJO, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$102,633
- ALIF$34,143
- XLIF$4,000
- Excelsius - GPS$3,850
- Hedron$260
- MONTEREY AL$175
- CASCADIA INTERBODY SYSTEM$150
- Other - Miscellaneous$142
- Valiant Captivia$140
- Endurant$106
How this compares
$147,408 in reported general payments places this provider in the 95th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 24 | $107 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Wayne
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
- Saum RahimiNew Brunswick$90K
- Michael LiebHainesport$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.